Evidence map›Paper›PMID 24897164›Full record

ArticleJournal of pediatric gastroenterology and nutrition2014

Health-related quality of life over time in children with eosinophilic esophagitis and their families.

Mary D Klinnert, Lori Silveira, Rachel Harris, Wendy Moore, Dan Atkins, David M Fleischer, Calies Menard-Katcher, Seema Aceves, Jonathan M Spergel, James P Franciosi and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of pediatric gastroenterology and nutrition, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Eosinophilic gastrointestinal diseases.Nature reviews. Disease primers · 2026
    Review
  3. Review
  4. Review
  5. [Eosinophilic esophagitis-an underestimated food allergy?]Dermatologie (Heidelberg, Germany) · 2025
    Review
  6. Review
  7. Review
  8. The Cellie Coping Kit for children with Eosinophilic Esophagitis: Feasibility, acceptability, and preliminary outcomes.Journal of child health care : for professionals working with children in the hospital and community · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. A diagnosis of eosinophilic esophagitis is associated with increased life insurance premiums.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mary D Klinnert*National Jewish Health, Denver, and University of Colorado School of Medicine, Aurora †National Jewish Health, Denver and University of Colorado School of Public Health, Aurora ‡Digestive Health Institute, Gastrointestinal Eosinophilic Diseases Program, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora §National Jewish Health, Denver and Children's Hospital Colorado and University of Colorado School of Medicine, Aurora ||Rady Children's Hospital and University of California, San Diego ¶Children's Hospital of Philadelphia and Perelman School of Medicine at University of Pennsylvania, Philadelphia #Division of Gastroenterology, Hepatology, and Nutrition, Nemours Children's Hospital and University of Central Florida College of Medicine, Orlando.
Lori Silveira
Rachel Harris
Wendy Moore
Dan Atkins
David M Fleischer
Calies Menard-Katcher
Seema Aceves
Jonathan M Spergel
James P Franciosi
Glenn T Furuta

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
Patient research in eosinophilic gastrointestinal diseasesK24DK100303 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI FURUTA, GLENN T · 2013 to 2017
$889k
NCATS NIH HHS UL1 TR000154NCATS NIH HHS UL1 TR001082NCRR NIH HHS UL1 RR025780NIDDK NIH HHS 1K24DK100303NIDDK NIH HHS K24 DK100303
6 · The paper itself

Abstract

objectivesExisting treatments for pediatric eosinophilic esophagitis (EoE) effectively reduce inflammation. The impact of treatment on health-related quality of life (HRQoL) over time for pediatric patients with EoE and their families, however, has not been systematically assessed. We hypothesized that individualized multidisciplinary treatment would improve both child and family HRQoL over time, with improvements associated with decreased symptom severity.

methodsChildren with EoE treated in 4 tertiary care centers were enrolled. Baseline assessments occurred at the time of patients' first evaluation; follow-up assessments occurred at 2 and 6 months after baseline. Presence and severity of 8 EoE symptoms were measured. HRQoL was measured with the Pediatric Quality of Life Inventory parent proxy report, child self-report (CR), and Family Impact Module (FIM). Statistical analyses used mixed-effects modeling to test changes over time for child and family HRQoL.

resultsNinety-seven children were enrolled (ages 2-18 years, mean age 7.7 years ± 4.8, 78% boys, 80% white). Baseline mean symptom number was 3.5 (standard deviation 2.3), and symptom severity was 5.5 (standard deviation, 4.5). HRQoL scores were significantly related to symptom scores (P < 0.001). EoE symptom severity decreased during the study (P = 0.03). Pediatric Quality of Life Inventory parent proxy Total and FIM Total scores improved from baseline to 6 months (respectively, adjusted means 78.4 vs 81.0, P = 0.0006; 68.9 vs 70.1, P = 0.03). Interactions with baseline symptom severity revealed that subjects with lowest symptom severity showed the most improved HRQoL scores (P = 0.0013).

conclusionsHRQoL improved during the course of evaluation and treatment, with positive changes being strongest for patients with less symptom severity at baseline.

Indexed as

Quality of LifeSeverity of Illness IndexAdministration, OralAdolescentAsthmaChildChild, PreschoolEczemaEosinophilic EsophagitisFamilyFemaleFood HypersensitivityHealth StatusHumansMaleProspective StudiesSteroids

Identifiers

PMID24897164
PMCPMC4141021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.